Objective: To investigate the surgical treatment of 15 patients with portal hypertension of secondary biliary cirrhosis due to hepatolithiasis(PHSBCH).
目的 :探讨 15例因肝胆管结石至胆管狭窄合并胆汁性肝硬变门脉高压症 (PHSBCH)的外科治疗。
primary biliary cirrhosis of liver
原发性胆汁性肝硬变(化)
extrahepatic obstructive biliary cirrhosis
肝外胆管阻塞性胆汁性肝硬变
Study Progression of Ursodeoxychlic acid (UDCA) in Treatment of Primary Biliary Cirrhosis for Primary Biliary Cirrhosis
熊去氧胆酸治疗原发性胆汁性肝硬化
Liver Function and Immunological Changes of Primary Biliary Cirrhosis
38例原发性胆汁性肝硬化患者的肝功能和血清免疫学变化特征
Surgical Treatment of Hepatolithiasis Associated with Secondary Biliary Cirrhosis;
肝胆管结石合并胆汁性肝硬化的外科治疗
Clinical Analysis of Primary Biliary Cirrhosis: A Report of 78 Cases;
78例原发性胆汁性肝硬化的临床分析
The Clinical Analysis of Primary Biliary Cirrhosis for 38 Cases;
原发性胆汁性肝硬化38例临床分析
Clinical Analysis of 48 Cases with Primary Biliary Cirrhosis
48例原发性胆汁性肝硬化的临床分析
Analysis of 21 Cases about Primary Biliary Cirrhosis
原发性胆汁性肝硬化21例临床分析
Clinical Aanalysis of 48 Patients with Primary Biliary Cirrhosis
48例原发性胆汁性肝硬化临床分析
Clinical characteristics of 38 cases with primary biliary cirrhosis
38例原发性胆汁性肝硬化的临床特征
Clinical features in 25 patients with primary biliary cirrhosis(PBC)
25例原发性胆汁性肝硬化临床特征
A Study on the Efficacy of Ursodeoxycholic Acid Combined Tongdan Decoction Treating 30 Patients with Primary Biliary Cirrhosis
熊去氧胆酸联合通胆汤治疗原发性胆汁性肝硬化研究
Clinical and Pathological Characterization of 83 Ases of Primary Biliary Cirrhosis;
83例原发性胆汁性肝硬化临床及病理分析
Clinical and Pathological Analysis of 21 Patients with Primary Biliary Cirrhosis
21例原发性胆汁性肝硬化临床资料与病理分析
Progress in the study of osteoporosis in primary biliary cirrhosis
原发性胆汁性肝硬化并发骨质疏松的研究进展
The Progress of Treatment and Pathogenesis of Primary Biliary Cirrhosis
原发性胆汁性肝硬化发病机制及治疗进展
Research Progress in Immune pathogenesis of Primary Biliary Cirrhosis
原发性胆汁性肝硬化免疫发病机制的研究进展
CopyRight © 2020-2024 优校网[www.youxiaow.com]版权所有 All Rights Reserved. ICP备案号:浙ICP备2024058711号